Ian Bezek

Ian Bezek

Ian Bezek earned his economics degree from Colorado State University in 2010. He then worked as an analyst for Kerrisdale Capital, a New York City-based activist hedge fund, from 2011-13. Since then, Ian has focused on finding under-the-radar investment opportunities, particularly overseas. To that end, he taught himself Spanish and has lived in Mexico and Argentina among other countries. He currently resides in Colombia with his family.

You can interact with Ian on Twitter.

Recent Articles

Should You Buy, Sell, Or Hold These 7 Medical Cannabis Stocks?

With cannabis stocks on fire, medical marijuana is the place to be. Here is the latest scoop on these seven leading medicinal pot stock plays.

Investors Should Sell Adobe Stock

Adobe stock has risen rapidly over the last month. As a result, it's a good time to take profits on ADBE stock ahead of what could be an underwhelming 2019.

Here’s What’s Next for Disney Stock After Disappointing Earnings

When will Disney stock finally get moving again? Here's what you need to know about the company's streaming service rollout in 2019.

7 Bank Stocks to Buy After the BB&T-Suntrust Mega-Merger

BB&T is buying Suntrust in a gargantuan $66 billion deal. Which banking stocks will benefit next as the M&A wave rolls in?

Zynerba Stock Is Marijuana-Adjacent Play Worth a Look

Zynerba has a CBD gel that looks like a promising treatment for various neurological diseases. What does it mean for ZYNE stock?

You Should Be Selling XBiotech Stock After the Huge Gains

XBiotech released promising clinical data. But it also comes with concerns, leaving XBIT stock vulnerable once momentum fades.

Take Two Stock Can Win Again After Earnings Loss

Analysts agree, TTWO stock is the best play of the video game stocks right now. Don't let earnings shake you out of the sector's top dog.

Amazon Stock Could Be Hurt by an Emerging Trend

Analysts expect Amazon Prime's torrid growth to continue. But they're overlooking a key risk factor for AMZN and AMZN stock.

Is iRobot Ready to Mow Down the Competition?

Bears argue that iRobot is about to get run over by competition. But don't count out IRBT stock just yet. There are other growth drivers.

5 of the Best Biotech Stocks to Buy Now

Biotech stocks are off to a hot start in 2019, and these five stocks, in particular, could be the next winners.